MCKESSON CORP
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 3/31/26
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 6,526 | 149.9 |
| Stockholders' equity | (2,172) | -49.9 |
| Total capitalization | 4,354 | 100.0 |
116,590,363 shares outstanding at 31 July 2026 (cover page of the 10-Q filed 5 August 2026).
LONG-TERM DEBT 3/31/26
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 6,526 |
| Long-term debt, noncurrent | 5,259 |
| Current maturities | 1,267 |
CAPITAL STOCK 3/31/26
| Common shares authorized | 800,000,000 |
| Common shares issued | 280,000,000 |
| Par or stated value per share ($) | 0.01 |
| Preferred stock ($ millions) | 0 |
| Outstanding at 7/31/26 | 116,590,363 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2026 | 3.17 | 8.3 |
| 2025 | 2.75 | 10.7 |
| 2024 | 2.40 | 10.7 |
| 2023 | 2.09 | 8.3 |
| 2022 | 1.83 | 25.3 |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware. Formerly known as MCKESSON HBOC INC (to 13 August 2001).
BUSINESS: Classified by the SEC under Standard Industrial Classification 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. Large accelerated filer. Principal executive office: 6555 State Highway 161, Irving, TX 75039. Fiscal year ends March 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 3/31/26 | 3/31/25 | 3/31/24 |
|---|---|---|---|
| Revenues | 403,430 | 359,051 | 308,951 |
| Cost of revenues | 388,880 | 345,728 | 296,123 |
| Gross profit | 14,550 | 13,323 | 12,828 |
| Selling, general and administrative | 8,096 | 8,507 | 8,657 |
| Depreciation and amortization | 287 | 272 | 279 |
| Operating income | 6,212 | 4,422 | 3,909 |
| Interest expense | 247 | 265 | 252 |
| Income before income taxes | 6,201 | 4,359 | 3,789 |
| Income taxes | 1,102 | 878 | 629 |
| Net income | 4,762 | 3,295 | 3,002 |
| Earned per share, diluted ($) | 38.38 | 25.72 | 22.39 |
| Dividends per share ($) | 3.17 | 2.75 | 2.40 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 3/31/26 | 3/31/25 |
|---|---|---|
| Cash and equivalents | 3,975 | 5,691 |
| Receivables, net | 27,985 | 25,643 |
| Inventories | 24,207 | 23,001 |
| Total current assets | 57,210 | 55,398 |
| Property, plant and equipment, net | 2,668 | 2,502 |
| Goodwill | 11,316 | 10,022 |
| Total assets | 82,323 | 75,140 |
| Total current liabilities | 67,017 | 61,604 |
| Long-term debt | 5,259 | 4,463 |
| Stockholders' equity | (2,172) | (2,074) |
| Total liabilities and equity | 82,323 | 75,140 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/31/26 | 403,430 | 6,212 | 4,762 | 1.2 | 38.38 | 3.17 | 6,155 | 436 | 5,719 | 82,323 | 84,100d | 6,526 | (2,172) | -219.2 | -3.00 |
| 3/31/25 | 359,051 | 4,422 | 3,295 | 0.9 | 25.72 | 2.75 | 6,085 | 537 | 5,548 | 75,140 | 76,834d | 5,654 | (2,074) | -158.9 | -2.73 |
| 3/31/24 | 308,951 | 3,909 | 3,002 | 1.0 | 22.39 | 2.40 | 4,314 | 431 | 3,883 | 67,443 | 69,042d | 5,629 | (1,971) | -152.3 | -2.86 |
| 3/31/23 | 276,711 | 4,381 | 3,560 | 1.3 | 25.03 | 2.09 | 5,159 | 390 | 4,769 | 62,320 | 63,810d | 5,594 | (1,857) | -191.7 | -3.01 |
| 3/31/22 | 263,966 | 2,038 | 1,114 | 0.4 | 7.23 | 1.83 | 4,434 | 388 | 4,046 | 63,298 | 65,090d | 5,879 | (2,272) | -49.0 | -2.59 |
| 3/31/21 | 238,228 | (5,040) | (4,539) | -1.9 | (28.26) | 1.67 | 4,542 | 451 | 4,091 | 65,015 | 64,840d | 7,148 | (21) | 21614.3 | -340.38 |
| 3/31/20 | 231,051 | 2,489 | 900 | 0.4 | 4.95 | 1.62 | 4,374 | 362 | 4,012 | 61,247 | 55,938d | 7,387 | 5,092 | 17.7 | 1.45 |
| 3/31/19 | 214,319 | 886 | 34 | 0.0 | 0.17 | 1.51 | 4,036 | 426 | 3,610 | 59,672 | 51,385d | 7,595 | 8,094 | 0.4 | 0.94 |
| 3/31/18 | 208,357 | 762 | 67 | 0.0 | 0.32 | 1.30 | 4,345 | 405 | 3,940 | 60,381 | 50,324d | 7,880 | 9,804 | 0.7 | 0.80 |
| 3/31/17 | 198,533 | 7,122 | 5,070 | 2.6 | 22.73 | 1.12 | 4,744 | 404 | 4,340 | 60,969 | 49,696d | 8,545 | 11,095 | 45.7 | 0.77 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
MCKESSON CORP
CIK 927653 · EIN 94-3207296
PRINCIPAL OFFICE:
6555 State Highway 161, Irving, TX 75039
Tel.: 972-446-4800
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 3/31/26, filed 8 May 2026
FORMER NAMES:
MCKESSON HBOC INC
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2026 (filed 5/8/26) · 10-K FY2025 (filed 5/9/25) · 10-K FY2024 (filed 5/8/24) · 10-K FY2023 (filed 5/9/23) · 10-K FY2022 (filed 5/9/22) · 10-K FY2021 (filed 5/12/21) · 10-K FY2020 (filed 5/22/20) · 10-K FY2019 (filed 5/15/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.